Evidence map›Paper›PMID 22064478›Full record

ArticleMolecular and cellular biology2012

Regulation of estrogen receptor α N-terminus conformation and function by peptidyl prolyl isomerase Pin1.

Prashant Rajbhandari, Greg Finn, Natalia M Solodin, Kiran K Singarapu, Sarata C Sahu, John L Markley, Kelley J Kadunc, Stephanie J Ellison-Zelski, Anastasia Kariagina, Sandra Z Haslam and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 76 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Incorporation of DThe journal of physical chemistry. B · 2022
    Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Prashant RajbhandariDepartment of Oncology and UW Carbone Comprehensive Cancer Center, University of Wisconsin—Madison, Madison, Wisconsin, USA.
Greg Finn
Natalia M Solodin
Kiran K Singarapu
Sarata C Sahu
John L Markley
Kelley J Kadunc
Stephanie J Ellison-Zelski
Anastasia Kariagina
Sandra Z Haslam
Kun Ping Lu
Elaine T Alarid
University of Wisconsin–Madison · USHarvard University · USMichigan State University · USUniversity of Wisconsin Carbone Cancer Center · US

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI AMY TRENTHAM-DIETZ · 1985 to 2026
$142.6M
Specialized Center for Eukaryotic Structural GenomicsU54GM074901 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI MARKLEY, JOHN LUTE · 2005 to 2009
$18.9M
WATER DISTRIB:PHYSICAL PROPERT:PIZZA &LMPS MOZZARELLA CHEESES:EARLY STAGE MATURP41RR002301 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI MARKLEY, JOHN LUTE · 1985 to 2011
$13.0M
Training Program In Molecular AND Cellular PharmacologyT32GM008688 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI AUDHYA, ANJON · 1998 to 2020
$6.0M
900 MHz NMR Spectrometer Biomolecular InvestigationsP41GM066326 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI MARKLEY, JOHN L · 2002 to 2006
$5.0M
Function and Regulation of Pin2/TRF1 and PinX1R01GM056230 · NIGMS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI LU, KUN PING · 1997 to 2005
$1.8M
Estrogen Receptor Alpha Proteostasis in Breast CancerR01CA159578 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI ALARID, ELAINE T · 2011 to 2015
$1.5M
NCI NIH HHS CA159578NCI NIH HHS P30 CA014520NCI NIH HHS R01 CA159578NCI NIH HHS U01 ES/CA012800NCRR NIH HHS P41 RR002301NCRR NIH HHS P41 RR02301NIGMS NIH HHS P41 GM066326NIGMS NIH HHS P41 GM66326NIGMS NIH HHS R01 GM056230NIGMS NIH HHS R01 GM56230NIGMS NIH HHS T32 GM008688NIGMS NIH HHS T32 GM08688NIGMS NIH HHS U54 GM074901
6 · The paper itself

Abstract

Estrogen receptor alpha (ERα), a key driver of growth in the majority of breast cancers, contains an unstructured transactivation domain (AF1) in its N terminus that is a convergence point for growth factor and hormonal activation. This domain is controlled by phosphorylation, but how phosphorylation impacts AF1 structure and function is unclear. We found that serine 118 (S118) phosphorylation of the ERα AF1 region in response to estrogen (agonist), tamoxifen (antagonist), and growth factors results in recruitment of the peptidyl prolyl cis/trans isomerase Pin1. Phosphorylation of S118 is critical for Pin1 binding, and mutation of S118 to alanine prevents this association. Importantly, Pin1 isomerizes the serine118-proline119 bond from a cis to trans isomer, with a concomitant increase in AF1 transcriptional activity. Pin1 overexpression promotes ligand-independent and tamoxifen-inducible activity of ERα and growth of tamoxifen-resistant breast cancer cells. Pin1 expression correlates with proliferation in ERα-positive rat mammary tumors. These results establish phosphorylation-coupled proline isomerization as a mechanism modulating AF1 functional activity and provide insight into the role of a conformational switch in the functional regulation of the intrinsically disordered transactivation domain of ERα.

Indexed as

AnimalsAntineoplastic Agents, HormonalBreast NeoplasmsCell Line, TumorDrug Resistance, NeoplasmEstrogen Receptor alphaFemaleGene Expression Regulation, NeoplasticHumansNIMA-Interacting Peptidylprolyl IsomerasePeptidylprolyl IsomerasePhosphorylationProtein BindingProtein Structure, TertiaryRatsRats, Sprague-DawleyAntineoplastic Agents, HormonalEstrogen Receptor alphaNIMA-Interacting Peptidylprolyl IsomerasePeptidylprolyl IsomerasePIN1 protein, humanTamoxifen

Identifiers

PMID22064478
PMCPMC3255769
OpenAlexW2100347281

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.